@MYTH@bubu :
oui papier toujours en ligne, c’est sur qu’on est loin de vos délires d’efficacité négative
BNT162b2 effectiveness against symptomatic BA.2 infection was highest at 51.7% (95% CI : 43.2–58.9%) in the first 3 months after the second dose, but then declined to -10% or below thereafter